Tetracycline compounds for treatment of cryptosporidium...

Details Tetracycline compounds for treatment of cryptosporidium... Tetracycline compounds for treatment of cryptosporidium...

2007-04-10

2007-04-10

Badio, Barbara P. (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

3,10-dihydroxy-2-naphthacene carboxamide or derivative doai

Reexamination Certificate

active

10982728

ABSTRACT:
Methods and compositions for treatingCryptosporidium parvumrelated disorders in a mammal are discussed. Several novel tetracycline compounds useful for treatingCryptosporidium parvumrelated disorders are also included.

REFERENCES:
patent: 2980584 (1961-04-01), Hammer
patent: 2990331 (1961-06-01), Neumann et al.
patent: 3062717 (1962-11-01), Hammer
patent: 3165531 (1965-01-01), Blackwood et al.
patent: 3454697 (1969-07-01), Joyner et al.
patent: 3557280 (1971-01-01), Weber et al.
patent: 3674859 (1972-07-01), Beutel et al.
patent: 3957980 (1976-05-01), Noseworthy
patent: 4018889 (1977-04-01), Armstrong
patent: 4024272 (1977-05-01), Rogalski et al.
patent: 4126680 (1978-11-01), Armstrong
patent: 5532227 (1996-07-01), Golub et al.
patent: 5639742 (1997-06-01), Lee et al.
patent: 5789395 (1998-08-01), Amin et al.
patent: 5834450 (1998-11-01), Su
patent: 6500812 (2002-12-01), Nelson et al.
patent: 6617318 (2003-09-01), Nelson et al.
patent: 6624168 (2003-09-01), Nelson et al.
patent: 6642270 (2003-11-01), Nelson et al.
patent: 6683068 (2004-01-01), Nelson et al.
patent: 6818634 (2004-11-01), Nelson et al.
patent: 6818635 (2004-11-01), Nelson et al.
patent: 6833365 (2004-12-01), Levy et al.
patent: 6841546 (2005-01-01), Draper et al.
patent: 6846939 (2005-01-01), Nelson et al.
patent: 6849615 (2005-02-01), Nelson et al.
patent: 7001918 (2006-02-01), Huss et al.
patent: 7045507 (2006-05-01), Draper et al.
patent: 7056902 (2006-06-01), Nelson et al.
patent: 7067681 (2006-06-01), Nelson et al.
patent: 2002/0128237 (2002-09-01), Nelson et al.
patent: 2002/0128238 (2002-09-01), Nelson et al.
patent: 2004/0048835 (2004-03-01), Nelson et al.
patent: 2004/0063674 (2004-04-01), Levy et al.
patent: 2004/0092490 (2004-05-01), Draper et al.
patent: 2004/0138183 (2004-07-01), Nelson et al.
patent: 2004/0152674 (2004-08-01), Levy et al.
patent: 2004/0176334 (2004-09-01), Nelson et al.
patent: 2004/0214800 (2004-10-01), Levy et al.
patent: 2004/0214801 (2004-10-01), Nelson et al.
patent: 2004/0242548 (2004-12-01), Draper et al.
patent: 2004/0266740 (2004-12-01), Huss et al.
patent: 2005/0020545 (2005-01-01), Draper et al.
patent: 2005/0026875 (2005-02-01), Nelson et al.
patent: 2005/0026876 (2005-02-01), Nelson et al.
patent: 2005/0038002 (2005-02-01), Nelson et al.
patent: 2005/0070510 (2005-03-01), Draper et al.
patent: 2005/0119235 (2005-06-01), Nelson et al.
patent: 2005/0137174 (2005-06-01), Ohemeng et al.
patent: 2005/0143352 (2005-06-01), Nelson et al.
patent: 2005/0143353 (2005-06-01), Nelson et al.
patent: 2005/0148551 (2005-07-01), Nelson et al.
patent: 2005/0187198 (2005-08-01), Nelson et al.
patent: 2005/0250744 (2005-11-01), Levy et al.
patent: 2005/0288262 (2005-12-01), Bandarage et al.
patent: 2006/0003971 (2006-01-01), Nelson
patent: 2006/0008463 (2006-01-01), Itoh et al.
patent: 2006/0008933 (2006-01-01), Muller et al.
patent: 2006/0014876 (2006-01-01), Bushelman et al.
patent: 2006/0016694 (2006-01-01), Tanaka et al.
patent: 2814974 (1984-06-01), None
patent: 2820983 (1984-06-01), None
patent: WO-93/08806 (1993-05-01), None
patent: WO-99/37306 (1999-07-01), None
Armson et al., “Assessment of drugs againstCryptosporidium parvumusing a simple in vitro screening method.” FEMS Microbiology Letters, vol. 178, pp. 227-233, 1999.
Armson A., et al. “Assessment of drugs againstCryptosporidium parvumusing a simple in vitro screening metho,”FEMS Microbiol Lett.Sep. 15, 1999;178(2):227-33.
Brites C., et al. “Multiple drug regimen for severe diarrhea associated withCryptosporidiumin AIDS patients,”Rev Soc Bras Med Trop.Apr.-Jun. 1991;24(2):117.
Current, W.L. et al., “A comparisomn of endogenous development of three isolates ofCrytosporidiumin suckling mice,”J. Protozoology33:98-108 (1986).
Current, W.L. et al., “Cryptosporidiosis,”Clin Microbiol. Rev.4(3):325-358 (1991).
Fayer R., et al. “Glycoside antibiotics alone and combined with tetracyclines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice,”J. Parasitol.Aug. 1993;79(4):553-8.
Fitchenbaum, C.J. et al., “Use of paromomycin for treatment ofCryptosporidiosisin patients with aids,”Critical Infectious Diseases16:298 (1993).
Flanigan T.P., et al. “Cryptosporidiosis,”Prog. Clin. Parasitol.3:1 (1993).
Keusch, G.T. et al., “Cryptospordia—Who is at risk?,”Schweiz Med Wochenschr.125(18):899-908 (1995).
Nelson, M.L. et al., “Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines,”J. Med. Chem.36(3):370-377 (1993).
Peterson, C., “Cryptosporidiosis in patients infected with the human immunodeficiency virus,”Clin. Infec. Dis.15:903 (1992).
Tzipori, S. et al. “Chronic cryptospordial diarrhoea and hyperimmune cow colostrum,”Lancet2(8554):344 (1987).
Tzipori, S., “Cryptosporidiosisin perspective,”Advances in Parasitology27:63-129 (1988).
Ungar, B.L.P. et al., “Cessation of cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum,”Gastroenterology98:486-489 (1990).

Affiliated with

Also associated with

Rating

Tetracycline compounds for treatment of cryptosporidium... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetracycline compounds for treatment of cryptosporidium..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetracycline compounds for treatment of cryptosporidium... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3770219